J

    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $2.32
    -0.02 (-0.85%)

    Market Cap: $174.71M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Dec 25
    		$0.01N/AN/ABeat-93.3%
    Jun 25
    		$0.00$0.00N/ABeat-100.0%
    Dec 24
    		$0.01$0.00N/ABeat-96.4%
    Dec 22
    		$0.34$0.00N/ABeat-
    Sep 22
    		$0.15$0.00N/ABeat-
    Sep 21
    		$0.23$0.00N/ABeat-
    Jun 21
    		$0.28$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio0.23EV/EBITDA236.44x
    Price/FCF-7.73xFCF Yield-12.94%
    Profitability
    Profit Margin5.95%Operating Margin-7.23%
    ROE4.02%ROIC-0.49%
    Financial Health
    Debt/Equity0.58xInterest CoverageN/A
    Current Ratio1.95xQuick Ratio1.64x
    Trading Statistics
    Beta7.34Avg Volume2.06M
    52-Week High$14.5252-Week Low$1.53

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.78
    SMA 20$2.78
    SMA 50$2.34
    SMA 200$2.92
    EMA 10$2.66
    EMA 20$2.66
    EMA 50$2.50
    EMA 200$3.89

    MACD

    Line: 0.06Signal: 0.17Hist: -0.11

    ADX

    ADX: 31.4+DI: 24.7-DI: 21.4

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down32.0
    PSAR$2.11

    Bollinger Bands

    Upper Band$3.78
    Lower Band$1.78
    %B Position7202%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    42.2

    Momentum Oscillators

    Stoch %KN/A
    Stoch %D17.8
    Williams %R-100.0
    ROC (10d)-32.9%
    Momentum-1.14
    CCI (20d)-68.7
    MFI (14d)61.3

    Volatility Measures

    ATR (14d)$0.34(14.8%)
    StdDev (20d)0.50
    Hist Vol184.2%(High)

    Volume Flow

    VWAP$2.35
    OBV68.3M
    AD Line39.2B
    CMF (20d)-0.098

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio0.0x(Low)
    VWMA (20d)$2.53

    Pivot Points

    R3$2.64
    R2$2.58
    R1$2.46
    Pivot Point$2.40
    S1$2.28
    S2$2.22
    S3$2.10

    Advanced Oscillators

    TSI6.25
    Ultimate Osc22.0
    KST402.19

    Financial Data

    QuarterJun 2026Dec 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$8.92M$10.81M$4.94M$9.88M$4.94M$12.95M$6.47M$10.56M$5.28M$9.57M$4.78M$10.25M
    Cost of Revenue$6.52M$7.16M$3.67M$7.35M$3.67M$7.13M$3.57M$6.76M$3.38M$6.31M$3.12M$6.62M
    Gross Profit$2.40M$3.64M$1.27M$2.53M$1.27M$5.81M$2.91M$3.80M$1.90M$3.25M$1.67M$3.63M
    Operating Expenses$3.04M$2.58M$1.49M$2.99M$1.49M$3.40M$1.70M$2.57M$1.28M$2.16M$1.08M$1.86M
    R&D$881,726$896,817$330,443$660,886$330,443$887,680$443,840$609,646$304,823$911,860$455,930$631,034
    SG&A$0$0$724,295$1.45M$724,295$1.72M$861,536$1.54M$769,340$499,590$499,590$922,188
    Operating Income$-644,453$1.06M$-227,106$-454,212$-227,106$2.41M$1.20M$1.23M$614,619$1.10M$547,902$1.77M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$215,064$215,064$119,600$0$0$0$0$0
    Income Before Tax$-305,046$1.57M$14,282$28,564$14,282$2.17M$1.09M$2.01M$1.01M$1.25M$625,769$1.97M
    Income Tax Expense$-96,042$195,006$9,783$19,566$9,783$454,866$227,433$309,014$154,507$139,654$69,827$204,052
    Net Income$-107,735$1.28M$-44,504$-89,008$-44,504$1.88M$940,917$1.79M$897,047$1.11M$555,941$1.77M
    EBITDA$-480,542$1.20M$-161,476$-322,952$-161,476$2.53M$1.26M$1.35M$674,642$1.36M$603,620$1.89M
    EBIT$-644,453$1.06M$-227,106$-454,212$-227,106$2.41M$1.20M$1.23M$614,619$1.25M$547,902$1.77M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ZJYL

    News

    Jin Medical (ZJYL) swaps $6.2M into 800-vote Class B shares

    Jin Medical International Ltd. (ZJYL) CEO Erqi Wang has solidified his voting control to approximately 98.12% through a recapitalization where Class A Ordinary Shares were repurchased and reissued as Class B Ordinary Shares, each carrying 800 votes. This move, costing $6.2 million, was made to maintain continuity in ownership and voting control ahead of a significant acquisition that is expected to issue additional Class A shares and potentially dilute existing holders. Despite holding only 6.77% of Class A shares, Wang’s control is vastly amplified by the high-vote Class B shares.

    Stock Titan•8/21/26•
    Neutral

    Erqi Wang Discloses Investment at Jin Medical International with 6.77% Stake

    Erqi Wang, CEO and chairman of Jin Medical International Ltd., has reported a 6.77% beneficial ownership in the company's Class A shares. This disclosure, made via a Schedule 13D filing, follows a recapitalization effort tied to the company's planned acquisition of Beijing Tongsheng Technology. The share swap mechanism strengthens Wang's voting control through high-vote Class B shares, allowing him to maintain long-term influence over Jin Medical's strategic direction.

    TradingView•8/21/26•
    Somewhat-Bullish

    Jin Medical International | SCHEDULE 13G: Others

    This article is a SCHEDULE 13G filing for Jin Medical International. A Schedule 13G is a simplified version of a Schedule 13D, used by passive investors to report beneficial ownership of 5% or more of a company's stock. The specific details of the filing are contained within the document.

    Moomoo•8/19/26•
    Neutral

    Chang Gil Lee controls 7.7M Jin Medical (NASDAQ: ZJYL) shares

    Chang Gil Lee, through NovastraList Horizon LTD, beneficially owns 7,702,376 Class A ordinary shares of Jin Medical International Ltd. (NASDAQ: ZJYL), representing 10.46% of the company's outstanding shares. Lee, as the sole owner and director of NovastraList Horizon LTD, has sole voting and dispositive power over these shares. This information was disclosed in a SCHEDULE 13G SEC filing.

    Stock Titan•8/18/26•
    Neutral

    Jin Medical International's (NASDAQ:ZJYL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

    Despite a market rally after its recent weak earnings report, Jin Medical International's future profitability looks concerning due to a high accrual ratio of 0.49 and negative free cash flow of US$7.0m. The analysis suggests that the company's statutory profits may not accurately reflect its underlying earnings power, potentially giving investors an overly optimistic view. Investors are advised to consider these warning signs and conduct further research beyond the reported profits.

    Webull•8/13/26•
    Bearish

    Frequently Asked Questions About ZJYL

    Does ZJYL pay dividends?
    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) does not currently pay a regular dividend.
    What is ZJYL's P/E ratio?
    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares has a price-to-earnings (P/E) ratio of 0.23.
    What is ZJYL's market cap?
    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a market capitalization of $174.71M with a current stock price of $2.32.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In